As of my last update in October 2023, there is limited publicly available information regarding the chemical substance identified as "MB076" with the CAS number "2832966-95-5." This compound may be a novel or less widely studied chemical, potentially related to specific research applications or pharmaceutical development. Typically, substances like this could exhibit unique properties such as specific solubility, stability, reactivity, and biological activity, depending on their molecular structure and functional groups. For accurate and detailed characteristics, including its physical and chemical properties, safety data, and potential applications, consulting specialized databases, scientific literature, or material safety data sheets (MSDS) would be essential. Additionally, if this compound is under investigation for therapeutic use, information may be available through clinical trial registries or pharmaceutical research publications. Always ensure to refer to the most current and reliable sources for the latest data on such substances.

MB076

2832966-95-5: As of my last update in October 2023, there is limited publicly available information regarding the chemical substance identified as "MB076" with the CAS number "2832966-95-5." This compound may be a novel or less widely studied chemical, potentially related to specific research applications or pharmaceutical development. Typically, substances like this could exhibit unique properties such as specific solubility, stability, reactivity, and biological activity, depending on their molecular structure and functional groups. For accurate and detailed characteristics, including its physical and chemical properties, safety data, and potential applications, consulting specialized databases, scientific literature, or material safety data sheets (MSDS) would be essential. Additionally, if this compound is under investigation for therapeutic use, information may be available through clinical trial registries or pharmaceutical research publications. Always ensure to refer to the most current and reliable sources for the latest data on such substances.

(R)-1-(2-(2-((5-Amino-1,3,4-thiadiazol-2-yl)thio)acetamido)-2-boronoethyl)-1H-1,2,3-triazole-4-carboxylic Acid

MB076 is an innovative heterocyclic triazole designed with enhanced plasma stability. It effectively inhibits seven distinct Class C Acinetobacter-derived cephalosporinases (ADCs) β-lactamase variants with K i values less than 1 μM. Additionally, MB076 demonstrates a synergistic effect when combined with various cephalosporins to restore pBCSK(−) susceptibility [1].

CAS 2832966-95-5

MB076

MB076

Ref: TR-M145750

(R)-1-(2-(2-((5-Amino-1,3,4-thiadiazol-2-yl)thio)acetamido)-2-boronoethyl)-1H-1,2,3-triazole-4-carboxylic Acid

Ref: ST-EA-CP-C12017

MB076

Ref: TM-T86864